Gerald Shulman
Endocrinology, Diabetes & Metabolism · New Haven, CTNPI 1235112319
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $166,323 of the $193,901 with a category attached, or 85.8%. 9 manufacturers reported payments, led by Janssen Research & Development, LLC at 48.4% of the total. Reporting peaked in 2019 at $79,149 and has fallen 90.0% since, to $7,941 in 2024. Among endocrinology, diabetes & metabolism clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $1919.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$94K
- Merck$43K
- Gilead$18K
- Astrazeneca UK Limited$11K
- Astrazeneca AB$9K
- Esperion Therapeutics, Inc.$8K
- plus $10K from 3 others
Across 7 payments — averaging $120,447 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$409K
- Astrazeneca AB$294K
- Gilead$140K
What the payments were for
- Consulting fees$166,32386%
- Travel & lodging$26,01813%
- Food & beverage$1,5601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 22 | $93,915 |
| Merck | 33 | $43,296 |
| Gilead | 25 | $18,409 |
| Astrazeneca UK Limited | 2 | $10,740 |
| Astrazeneca AB | 4 | $9,480 |
| Esperion Therapeutics, Inc. | 4 | $8,245 |
| Novo Nordisk | 9 | $6,205 |
| Theratechnologies Inc. | 1 | $2,000 |
| AstraZeneca | 1 | $1,611 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$193,901 in reported general payments places this provider in the 90th percentile of 177 endocrinology, diabetes & metabolism providers in Connecticut.
See all endocrinology, diabetes & metabolism providers in Connecticut →
Other endocrinology, diabetes & metabolism in New Haven
- Ania JastreboffNew Haven$536K
- Silvio InzucchiNew Haven$461K
- Philip GoldbergNew Haven$324K
- Kevan HeroldNew Haven$261K
- Karl InsognaNew Haven$68K
- Clemens BergwitzNew Haven$31K
- Richard KibbeyNew Haven$18K
- Peter TebbenNew Haven$17K
- Surani FernandoNew Haven$13K
- Irina RosewaterNew Haven$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.